Cargando…
Outcome of Living-Donor Liver Transplantation Using Grafts from Donors Treated for Fatty Liver
BACKGROUND: The aim of this study was to determine the efficacy of treating donors’ fatty liver (FL) and to assess early graft function in recipients who received treated FL grafts in living-donor liver transplantation (LDLT). MATERIAL/METHODS: Data were collected for adult-to-adult LDLTs. Donors di...
Autores principales: | Fujii, Yuki, Kawamura, Norio, Zaitsu, Masaaki, Watanabe, Masaaki, Goto, Ryoichi, Kamiyama, Toshiya, Taketomi, Akinobu, Shimamura, Tsuyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977639/ https://www.ncbi.nlm.nih.gov/pubmed/31919339 http://dx.doi.org/10.12659/AOT.920677 |
Ejemplares similares
-
The impact of preformed donor‐specific antibodies in living donor liver transplantation according to graft volume
por: Goto, Ryoichi, et al.
Publicado: (2022) -
Long‐term risk of a fatty liver in liver donors
por: Goto, Ryoichi, et al.
Publicado: (2023) -
Petersen’s hernia after living donor liver transplantation
por: Sakamoto, Sodai, et al.
Publicado: (2017) -
Living Donor Liver Transplantation for Hepatic Venoocclusive Disease/Sinusoidal Obstruction Syndrome Originating from Hematopoietic Stem Cell Transplantation
por: Ichimura, Kentaro, et al.
Publicado: (2022) -
Post-transplant donor-specific anti-HLA antibodies with a higher mean fluorescence intensity are associated with graft fibrosis in pediatric living donor liver transplantation
por: Goto, Ryoichi, et al.
Publicado: (2023)